Eight linear cationic peptides with cytolytic and insecticidal activity, designated cyto-insectotoxins (CITs), were identified in Lachesana tarabaevi spider venom. The peptides showed antibiotic activity towards Gram-positive and Gram-negative bacteria at micromolar concentrations as well as toxicity to insects. The primary structures of the toxins were established by direct Edman sequencing in combination with enzymatic and chemical polypeptide degradation and MS. CITs represent a novel class of cytolytic molecules and spider venom toxins. They are the first example of molecules showing equally potent antimicrobial and insecticidal effects. Analysis of L. tarabaevi venom gland expressed sequence tag database revealed the primary structures of the protein precursors; eight peptides homologous with the purified toxins were additionally predicted. CIT precursors share a conventional prepropeptide structure with an acidic prosequence and a processing motif common to most spider toxin precursors. The most abundant peptide, CIT 1a, was chemically synthesized, and its lytic activity on different bacterial strains, human erythrocytes and lymphocytes, insect cells, planar lipid bilayers and lipid vesicles was characterized. The spider L. tarabaevi is suggested to have evolved to rely on a unique set of linear cytolytic toxins, as opposed to the more common disulfide-containing spider neurotoxins.
INTRODUCTION
Animal venoms represent complex mixtures of compounds that serve a common offensive (prey capture) or defensive (aggressor deterrence) goal. During evolution, the venom components have been selected to best suit their function. At least four basic strategies of venom composition development have been proposed: (i) increase in the number of functionally diverse compounds; (ii) production of highly specific and efficient molecules; (iii) synergism between compounds; and (iv) biomolecular diversity of compounds, i.e. an increase in the number of functionally similar compounds [1, 2] . The last strategy has been the focus of our recent investigations [2] .
In spiders, venoms typically contain proteins, peptides and low-molecular-mass substances; peptides usually constitute the major part of the whole venom. Most spider venom peptides are classified into two large groups: the disulfide-containing neurotoxins, usually forming the ICK (inhibitor cystine knot) fold, and linear cytolytic peptides [3] . The size of spider neurotoxins varies in the ∼ 3-7 kDa range, whereas cytolytic peptides are typically rather small (∼ 3 kDa) [1] ; the longest linear peptide identified so far consists of 48 amino acid residues [4] .
Spiders are thought to mainly rely on the neurotoxic part of their venom arsenal. Peptide neurotoxins constitute natural combinatorial libraries that have been well-tuned in the course of spider evolution to select for the best-acting molecules that hit different targets in the prey/aggressor nervous system [5] . In contrast, linear cytolytic peptides found in spider venoms are considered to play a more accessory role provided that they do not target a specific receptor, but rather affect cell membranes with broad specificity. Several suggestions of the exact function of these peptides have been made [1] . For example, direct toxic effect on prey was proposed for lycotoxins from the venom of the spider Lycosa carolinensis (Lycosidae) [6] , cupiennins from Cupiennius salei (Ctenidae) [7] and oxyopinins from Oxyopes kitabensis (Oxyopidae) [4] , just as originally for melittin, the major component of the honey bee venom [8] . However, this effect is rather moderate compared with the action of neurotoxins. Venom cytolytic peptides may act as a spreading agent that facilitates neurotoxin passage through cellular barriers and eventually ensures its access to the target neurons. Positive co-operativity with neurotoxins has been reported for cupiennins [7] and oxyopinins [4] . A direct antiseptic role has been suggested for lycotoxins [6] , cupiennins [7] , latarcins [2] and previously for ponericins from the venom of the ant Pachycondyla goeldii [9] , which may play a disinfecting and possibly conserving role in paralysed prey. An additional function in venom gland protection has also been questioned [1] .
In the present paper, we describe CITs (cyto-insectotoxins), cytolytic peptides produced by the Central Asian spider Lachesana tarabaevi that represent a novel unique class of spider venom constituents. These linear cationic peptides are unexpectedly long (molecular mass ∼ 8 kDa), and, apart from clearly antimicrobial and cytolytic properties, exhibit strong insecticidal activity. They are also the major components of the venom and therefore their crucial role in the spider biology seems apparent.
Isolation and purification of CITs
Venom of L. tarabaevi (freeze-dried powder) was purchased from Fauna Laboratories. An aliquot (12.5 µl) of crude venom (collected from several individuals) was fractionated using size-exclusion chromatography on a TSK 2000SW column (7.5 mm × 600 mm, 10 µm pore size; Beckman). The mobile phase contained 150 mM NaCl in 30 mM NaH 2 PO 4 , and the flow rate was 0.5 ml/min. Effluent absorbance was monitored at 210 nm. Active fractions were separated further by RP (reverse-phase)-HPLC on a Vydac 218TP54 C 18 column (4.6 mm × 250 mm, 30 nm pore size, 5 µm particle size; Separations Group). A long 90-min linear gradient of acetonitrile (0-60 %, v/v) in 0.1% (v/v) aqueous TFA (trifluoroacetic acid) with a flow rate of 1 ml/min was used. Effluent absorbance was monitored at 280 nm. Fractions containing CITs were purified to homogeneity on a Jupiter C 5 column (2 mm × 150 mm, 30 nm pore size, 5 µm particle size; Phenomenex). The separation was carried out using a 60-min linear gradient (25-45 %) of acetonitrile in 0.1 % (v/v) aqueous TFA at a flow rate of 0.3 ml/min.
Mass spectrometry
Separated fractions as well as peptide fragments were analysed by MALDI (matrix-assisted laser-desorption ionization)-TOF (timeof-flight)-MS. M@LDI-LR (Micromass) and Ultraflex TOF-TOF (Bruker Daltonik GmbH) spectrometers were used. Calibration was performed using either a ProteoMass peptide and protein MALDI-MS calibration kit (mass range 700-66 000 Da) or a ProteoMass peptide MALDI-MS calibration kit (mass range 700-3500 Da) (both from Sigma). Molecular masses were determined in linear or reflector positive-ion mode using samples prepared using the dried-droplet method with 2,5-dihydroxybenzoic acid (10 mg/ml in 70 % acetonitrile with 0.1 % TFA) or α-cyano-4-hydroxycinnamic acid (10 mg/ml in 50 % acetonitrile with 0.1 % TFA) matrix. MS/MS (tandem MS) analysis was performed on the latter instrument according to the manufacturer's guidelines.
Amino acid sequence analysis
N-terminal sequencing was carried out by automated stepwise Edman degradation using a Procise Model 492 protein sequencer (Applied Biosystems) according to the manufacturer's protocol.
CNBr cleavage
Peptides were dried and redissolved in 80 % TFA to a concentration of 0.1-1 µg/µl. CNBr (5 M) solution in acetonitrile was added with a 1000-molar excess over methionine residues, and the samples were incubated overnight at room temperature (24 • C) in the dark. The reaction was terminated by adding 10 vol. of water, and the samples were then dried on a vacuum concentrator and redissolved in 0.1 % TFA. The mixture was analysed by MALDI-MS, and the products were separated by means of RP-HPLC on a Luna C 18 column (1 mm × 150 mm, 10 nm pore size, 3 µm particle size; Phenomenex) in a linear gradient of acetonitrile (0-60 %, v/v) in 0.1 % (v/v) aqueous TFA for 60 min at a flow rate of 50 µl/min.
Endoproteinase Arg-C cleavage
Peptides were dried and redissolved in 100 mM ammonium bicarbonate to a final concentration of 1 µg/µl. Endoproteinase Arg-C (Sigma) was added (enzyme/protein ratio of 1:50, w/w), and the samples were incubated for 4 h at 37
• C. A 1:10 mixture aliquot was desalted using ZipTip (Millipore) and analysed directly by MALDI-MS. The products were separated by means of RP-HPLC on a Luna C 18 column as described in the previous section.
Peptide synthesis
CIT 1a was synthesized on a peptide synthesizer Syro I (MultiSynTech GmbH) using Fmoc/t-butyl chemistry. The following side-chain protections were used: t-butyl ether for serine, threonine and tyrosine; t-butyl ester for aspartate and glutamate; trityl for asparagine and glutamine; t-butyloxycarbonyl for lysine and tryptophan; and 2,2,4,6,7-pentamethyldehydrobenzofuran-5-sulfonyl for arginine. The peptide was synthesized on a trityl chloride resin (0.8 mmol/g) (PepChem). Fmoc-protected amino acids were coupled by in situ activation using N,N -di-isopropylcarbodi-imide/1-hydroxybenzotriazol; as the peptide grew longer, the ratio of acylating species over amine was increased from 5:1 to 15:1, and the acylation time was increased to 2 h or more. The Fmoc-protecting-group removal, peptide cleavage from the resin, side-chain deprotection and the target product purification were carried out as described in [2] . Final 95 % purity of synthetic CIT 1a was achieved, which was verified by RP-HPLC on a Luna C 18 column and by MALDI-MS.
UV absorbance spectroscopy
Absorption spectra were recorded on an SF-256 spectrophotometer (LOMO). Polypeptide concentrations were determined using molar absorption coefficients at 280 nm (ε 280 ) calculated using the GPMAW program (Lighthouse Data): 9530 M −1 · cm
for CIT 1a and 1280 M −1 · cm −1 for Ltc 2a (latarcin 2a).
Preparation of LUVs (large unilamellar vesicles)
For CD studies, dry DOPC (dioleoyl phosphatidylcholine) was dissolved in chloroform/methanol mixture (2:1, v/v). The solvent was then evaporated using a 5301 concentrator (Eppendorf AG), and the resulting film was dried under vacuum for 2 h. The lipid film was resuspended in an aqueous solution containing 110 mM NaCl and 50 mM Na 2 HPO 4 (pH 7.5). The resulting 10 mM suspension of DOPC was subjected to ten cycles of freezing (liquid nitrogen) and thawing (45 • C) and was then extruded (21 times at 20
• C) through a 100-nm-pore-size polycarbonate membrane (Whatman) using a Mini-Extruder (Avanti Polar Lipids).
For vesicle lysis studies, lipid mixtures in chloroform were dried in a stream of argon. The traces of solvent were removed under vacuum (overnight). Dry lipid film was hydrated with buffer solution containing 50 mM NaCl, 20 mM Hepes, 12.5 mM ANTS (8-aminonaphthalene-1,3,6-trisulfonic acid) fluorescent dye and 45 mM DPX (p-xylenebispyridinium bromide) quencher (pH 7.0). Lipid concentration in the suspension was 1 mg/ml. After thorough vortex-mixing, the suspension was passed through ten cycles of freeze-thaw, and then liposomes were extruded (see above). The resulting LUV suspension was washed on a PD-10 desalting column (Amersham Biosciences) to remove the nonencapsulated dye.
Circular dichroism
CD spectra were recorded using a J-810 spectropolarimeter (Jasco). The spectra were measured between 190 and 250 nm (0.2 nm step) at 20
• C. A 0.01-cm-pathlength cell (quartz SUPRA-SIL) with a detachable window (Hellma GmbH and Co. KG) was used. CD spectra were measured for CIT 1a in water at 120 µM, 50 % (v/v) trifluoroethanol at 60 µM, 25 mM SDS at 60 µM and LUV suspension prepared from DOPC (5 mM) at 30 µM. CIT 1a secondary structure was analysed using the CONTINLL program [10] .
Antimicrobial assays
Bacteria (Arthrobacter globiformis VKM Ac-1112, Bacillus subtilis VKM B-501, Escherichia coli C600, E. coli DH5α, E. coli MH1, Micrococcus luteus VKM Ac-2230, Pseudomonas aeruginosa PAO1, Pseudomonas fluorescens VKM B-894, Serratia marcescens VKM B-1248 and Staphylococcus aureus 209P) were cultured in low-salt LB (Luria-Bertani) broth. Determination of MICs (minimal inhibitory concentrations) was performed using a microtitre broth dilution assay. Midexponential phase cultures were diluted to a final concentration of 10 5 colony-forming units/ml. Dried HPLC fractions or pure peptides were dissolved in 10 µl of water and added to 90 µl of the diluted bacterial suspension. The peptides, a non-treated control and a sterility control were tested in triplicate. The microtitre plates were incubated for 24 h at 37
• C; growth inhibition was determined by measuring absorbance at 620 nm. MICs are expressed as the lowest concentration of peptide which caused 100 % growth inhibition.
Haemolytic assays
The haemolytic activity of polypeptides was determined using fresh capillary human blood (taken with donor consent and according to Ministry of Health and Social Development of Russian Federation guidelines), which was mixed with RPMI 1640 medium (PanEco) containing heparin (10 units/ml) to give a final concentration of 10 7 cells/ml. The blood cells were incubated with serially diluted polypeptides at 37
• C for 3 h with gentle stirring. After centrifugation at 3000 g for 5 min, haemoglobin release was estimated by measuring the absorbance of the supernatant at 414 nm (A 414 ). Controls for zero haemolysis and 100 % haemolysis contained the same amount of blood cells resuspended in RPMI 1640 medium with heparin and distilled water respectively. The zero-haemolysis supernatant A 414 was very low, indicating the lack of spontaneous haemolysis induced by manipulations with cells. The relative A 414 compared with that of the suspension treated with distilled water defined the percentage of haemolysis. Experimental data on the concentration-dependence of haemolysis were fitted with a Hill function. Haemolytic activity of the peptides was characterized by the effective concentration inducing a 50 % release of haemoglobin (EC 50 ).
Toxicity for human leucocytes and insect Sf9 cells
Spodoptera frugiperda (Sf9) cells were cultured at 27
• C in TC-100 medium (Gibco-BRL, Invitrogen) supplemented with 10 % fetal bovine serum (HyClone) and 2 mM L-glutamine (PanEco). The leucocyte-enriched blood fraction was obtained as follows (taken with donor consent and according to Ministry of Health and Social Development of Russian Federation guidelines). Freshly collected human venous blood was subjected to precipitation by incubating at room temperature for 2 h in the dark. A buffy coat was collected and washed two times with RPMI 1640 medium supplemented with 8 % fetal bovine serum. The Sf9 cells or leucocytes (10 6 cells/ml) were incubated with serially diluted polypeptides for 3 h under 5 % CO 2 at 37
• C, and stained with Hoechst 33342 (10 µM) and propidium iodide (10 µM) for 10 min. Each concentration was tested in several repeats. The stained cells were examined using an Axiovert 200M fluorescence microscope (Carl Zeiss) and classified (500-1000 cells per point) as dead [Hoechst 33342 (+), propidium iodide (+)] or viable [Hoechst 33342 (+), propidium iodide (−)]. Experimental data were fitted with a Hill function. Cytotoxic activity of the peptides was characterized by the effective concentration inducing 50 % cell death (EC 50 ).
Insecticidal assays
Synthetic peptides were assayed by injection into flesh fly Sarcophaga carnaria maggots (∼ 50-60 mg), adult flies (∼ 20 mg) and speckled cockroaches (Nauphoeta cinerea) (∼ 150 mg). Samples were dissolved in physiological saline (140 mM NaCl, 5 mM KCl, 5 mM CaCl 2 , 1 mM MgCl 2 , 4 mM NaHCO 3 and 5 mM Hepes, pH 7.2), and a volume of 2 µl was injected into the fourth segment of fly larva, into the fly thorax or into the second thoracic segment of cockroaches. Groups of three to five individuals were used for every concentration tested. Controls received pure saline. Paralytic and lethal effects were monitored for up to 24 h after the injection.
Mouse toxicity assays
Balb/c female mice (∼ 10-15 g) were injected with samples dissolved in normal saline (10-40 µl for intravenous or intraperitoneal injections, and 2-5 µl for intracerebroventricular injections). Three to five individuals were used for every concentration tested. Negative controls were established by injecting normal saline solution alone. Toxic effects were observed for 24 h following the injection.
Planar lipid bilayer membrane assays
CIT 1a was tested for ability to cause conductance changes in planar bilayer membranes. Bilayers were formed (painted) across a 200 µm aperture in a horizontal Teflon septum separating two 2 ml chambers of the experimental cell using the technique of Mueller et al. [11] . DPhPC (diphytanoyl phosphatidylcholine) and a mixture of DOPE (dioleoyl phosphatidylethanolamine) and DOPG (dioleoyl phosphatidylglycerol) (7:3, w/w) were used to mimic eukaryotic and prokaryotic plasma membranes respectively. Membranes were formed from lipid solution in decane (20 mg/ml). Electrical measurements were performed at room temperature using Ag/AgCl electrodes in 100 mM KCl solution buffered with 10 mM Hepes (pH 7.0). Peptides dissolved in water were added to the upper (cis) chamber. Current across the membrane was measured with an Axopatch 200B amplifier (Axon Instruments) and digitized with an L-780 ADC (L-card). The cis-chamber was referred to as ground, whereas the transchamber was clamped at holding potentials relative to ground. The starting peptide concentration was 50 nM. Negative voltages across the membranes were applied starting from −20 mV with 10 mV steps until −100 mV was reached. If the membrane remained intact and no current was detected, higher peptide concentrations were tested.
Artificial vesicle assay
LUVs of three types of lipid composition were used: DPhPC, DOPE/DOPG (7:3, w/w) and total lipid from Sarcophaga carnaria fly larvae. The total lipid extract was prepared according to Folch et al. [12] . Briefly, insects were homogenized, and lipid extraction was carried out using chloroform/methanol mixture (1:2, v/v). The extract was washed with distilled water and freezedried. LUVs containing the ANTS fluorescent dye were prepared by extrusion (see above). Peptide lytic activity was monitored by observing the dye release from the LUVs. ANTS is characterized by the excitation maximum at 355 nm and the emission maximum at 530 nm. The dye is quenched inside the LUVs, and fluorescence increases as the dye is diluted after LUV lysis. Peptide solution in water was added at different concentrations, and fluorescence increase was measured using a Hitachi F-400 fluorescence spectrophotometer. The final LUV concentration was 5 µg/ml (total lipid). Maximum (i.e. 100 %) dye leakage was reached using Triton X-100. Fluorescence increase (%) was quantified using the following formula: 100 × (I−I 0 )/(I T −I 0 ), where I is the observed fluorescence intensity after addition of the peptide, I 0 is the background fluorescence measured without the peptide, and I T fluorescence intensity corresponds to 100 % dye leakage.
RESULTS

CIT purification
The venom of the spider L. tarabaevi (by classification of Zonstein and Ovtchinnikov, 1999) from the Zodariidae family was initially found to possess both high antimicrobial activity against E. coli (MIC = 0.05 mg/ml) and high insecticidal activity against flesh fly larvae (LD 50 = 20 µg/g). The former venom property served as a basis for search of new antimicrobial agents. This led to identification of a number of short linear AMPs (antimicrobial peptides) and cytolytic peptides named latarcins [2] . However, these peptides do not account for the latter venom property: their toxicity is negligible compared with the crude venom. Moreover, cytolytic components different from latarcins were also detected during testing of chromatographic fractions.
To isolate the principal insecticidal as well as novel cytolytic and antimicrobial compounds, the venom was subjected to a two-step chromatographic separation (Figure 1 ). The first step was gel filtration ( Figure 1A ). The active insecticidal fraction was separated further using RP-HPLC ( Figure 1B ). Using the approach described, we purified four different major venom constituents that exhibited both antimicrobial and insecticidal activities. These components with molecular masses of ∼ 8 kDa were named CITs and were characterized further in greater detail. Figure 1 (C) shows purification of CIT 1a, the most abundant component; other CITs were isolated from neighbouring fractions using the same protocol. Additionally, three other polypeptides that showed similar properties (chromatographic retention time, molecular mass) but lower abundance were detected. Relative abundance of CITs in the crude venom was estimated from the chromatographic peak areas. CITs are considered to be major venom components (∼ 20 % of total protein).
CIT structure
The purified four major components were completely sequenced using a combination of Edman degradation, MS and site-specific proteolysis. The peptides were named CIT 1a, 1f, 1g and 1h (Figure 2 ). The strategy that was used to obtain full amino acid sequences of these components is shown in Figure 3 . Briefly, direct Edman degradation provided partial N-terminal sequences of 38 amino acid residues. Specific CNBr cleavage at methionine residues and endoproteinase Arg-C cleavage at arginine residues were performed; the resulting peptide fragments were analysed by MALDI-MS and sequenced. In the case of CIT 1a, 1f and 1g, similar fragments resulting from CNBr cleavage were fully sequenced and compared with the initial N-terminal sequence, which resulted in complete primary structure determination of the peptides. We note that C-terminal homoserine lactone residues formed during CNBr cleavage were unambiguously determined using MS/MS. Moreover, measured molecular masses of all fragments as well as the source peptides matched the calculated values.
In the case of CIT 1h, no methionine residues were observed among the directly sequenced 38 N-terminal residues. However, only one arginine residue was detected. Therefore endoproteinase Arg-C was used to specifically hydrolyse the peptide. Although additional fragments resulting from cleavage at lysine residues were produced (omitted from Figure 3 for clarity), we managed to separate the two fragments that made up the whole sequence as suggested by their measured molecular masses. The smaller fragment corresponded to the N-terminal part of CIT 1h. The larger fragment was sequenced up to the methionine residue, then CNBr cleavage was performed, the fragments were sequenced, and the full peptide primary structure was thus established.
During direct sequencing of CIT 1a, microheterogeneity was observed at position 25: a minor leucine peak was detected together with the major isoleucine. This minor component was named CIT 1b. Other lower-abundance components' primary structures were also established, but no direct sequencing was performed. The peptides were cleaved with CNBr, and the resulting fragments were analysed by MS/MS, CIT 1a served as Names of peptides identified in the venom are shown in boldface; the major peptides' names are underlined. Amino acid residues that differ from the corresponding residues in CIT 1a sequence are shaded. Methionine and arginine residues are shown in boldface. Masses were calculated using GPMAW software. *Free thiol groups.
Figure 3 CIT structure determination
Full established sequences of CIT 1a, 1f, 1g and 1h are shown. Sequences of CIT 1f and 1g are aligned with CIT 1a, and the different residues are shown. Methionine and arginine residues targeted during specific polypeptide-chain fragmentation are shown in boldface. N-terminal amino acid sequences established using direct Edman fragmentation are indicated with arrows above the corresponding sequences. Peptides released during CIT cleavage with CNBr or endoproteinase Arg-C are indicated with arrows below the corresponding sequences.
reference. MS/MS sequencing resulted in identification of three more CITs, 1c, 1d and 1e, that differ from CIT 1a by single amino acid substitutions at positions 53, 33 and 14 respectively.
In total, eight novel polypeptides with antimicrobial and insecticidal activities were identified in L. tarabaevi venom and their primary structures were established. None of the peptides was Cterminally amidated, as suggested by the measured molecular masses of the C-terminal fragments that matched the calculated values.
CITs (CIT 1a-1h) ( Figure 2 ) represent a novel discovered type of spider venom constituents. They show negligible similarity to other known peptide and protein sequences. CITs contain 69 amino acid residues. Among these, there are no cysteine residues, whereas lysine residues are obviously prevalent (∼ 30 %). CITs are linear strongly charged cationic molecules (pI > 10, net charge + 14 at pH 7). Hydrophobic residues account for > 40 % of CIT sequence and, together with cationic residues, are arranged in a regular manner common to a vast group of linear cytolytic peptides and AMPs. This regular distribution allows the peptide to form a clearly amphipathic structure with clusters of hydrophobic and positively charged residues in an α-helical conformation.
CITs show a high degree of sequence similarity between each other. CIT 1a was chosen for extended studies since it was found to be the most abundant peptide in the venom. To this end, CIT 1a was chemically synthesized to provide sufficient material.
Venom gland EST (expressed sequence tag) database analysis
The fully determined amino acid sequences of CITs were used to query the L. tarabaevi venom gland EST database (obtained in collaboration with DuPont Agriculture & Nutrition). As a result, structures of CIT protein precursors were retrieved. Moreover, eight sequences that show extended homology with the purified CITs were identified. The predicted peptides were named CIT 1-6, 1-9, 1-10 and 1-12-1-16 ( Figure 2 ). In total, 16 CIT sequences (eight putative) were found in the EST dataset.
CIT precursors were named pCIT 1-1-1-16 ( Figure 4 ). These proteins represent conventional prepropeptide structures common to secreted polypeptides including many AMPs and toxins. Putative typical N-terminal signal (pre-) peptides (leader sequences) identified using the SignalP 3.0 program (available at http://www.cbs.dtu.dk/services/SignalP/) are followed by acidic prosequences that are removed post-translationally. These prosequences are characterized by a high abundance of negatively charged amino acid residues (∼ 40 %, pI < 4, net charge −14/−15 at pH 7) and hydrophobic residues (∼ 40 %). The mature peptides correspond to the C-terminal parts of precursors. No pCIT was found to bear an additional C-terminal glycine residue, which provides additional evidence for the absence of C-terminal amidation of the mature peptides. The propeptide cleavage occurs at a specific site known as the PQM (processing quadruplet motif) common to precursors of spider venom toxins and AMPs [13] . CIT precursors have been classified as simple precursors as described previously [2] .
As seen in Figure 4 , the precursor sequences share over 90 % identity with each other, and the differences in sequences are concentrated in the mature chains, whereas the pre-and prosequences are identical in most cases. We note that the EST fragment for pCIT 1-12 has some ambiguity in the signal peptide coding region, and the EST fragment for pCIT 1-15 contains incomplete sequence information.
CD spectra
The results of a CD spectroscopy study ( Figure 5 , Table 1 ) demonstrate that CIT 1a has a random coil structure in water and adopts an α-helical structure in 50 % trifluoroethanol solution and SDS micelles. CIT 1a binds effectively to DOPC liposomes, but the number of binding sites per liposome is limited. Conditions suitable for CD spectrum measurements correspond to saturation of binding, and the free form of peptide is present in the DOPC LUV suspension. As a result, the calculated α-helix content is underestimated.
Biological activities of CITs
CITs were purified using their antimicrobial and insecticidal activities to test the fractions. Approximate MICs (low Table 2 . In general, CIT 1a is active at low micromolar concentrations, although certain specificity of action is revealed, with some bacteria essentially resistant to the peptide. Both properties, wide spectrum of activity at micromolar concentrations and membrane specificity, are common to most other AMPs. These phenomena are explained by the suggested universal mechanism of AMP action with plasma membrane serving as the target.
Tests to determine various cytolytic activities of CIT 1a were also performed. Human erythrocytes were lysed at micromolar peptide concentrations (EC 50 = 6 µM). CIT 1a was also found to be toxic to human leucocytes (EC 50 = 3 µM), and ovarian insect Sf9 cells (EC 50 = 1 µM) in the same concentration range. CIT 1a caused lethal effects on flesh fly larvae (LD 50 of ∼ 20 µg/g) and was more active on adult flesh flies (LD 50 of ∼ 5 µg/g), but was much less active on cockroaches (LD 50 of ∼ 500 µg/g). In fly larvae, doses twice the LD 50 and higher caused instant paralysis and death in a short time (< 30 min). At doses close to and lower than the LD 50 , paralysis and liquid flow out of the injection opening occurred, in common with other AMPs. Similar effects were observed in adult flies.
Synthetic CIT 1a was compared with the natural peptide and was found to be equally active on B. subtilis, E. coli and flesh fly larvae. Activities on other cells and animals were not compared, owing to the lack of the natural peptide material.
Ltc 2a purified from the same spider venom in a previous study [2] was used as a reference linear cytolytic peptide with a classically broad specificity. Curiously, CIT 1a toxicity was 20-fold higher for the insect Sf9 cells than that of Ltc 2a (EC 50 = 1 µM and 20 µM respectively). Compared with CIT 1a, Ltc 2a was much less active on insects: at doses of ∼ 100 µg/g, it produced only reversible paralytic effect on fly larvae and adult flies, whereas it was totally inactive on cockroaches at doses of up to 250 µg/g, and produced partial paralysis at ∼ 750 µg/g. In contrast, CIT 1a was relatively as active on mice as Ltc 2a: at doses of ∼ 0.3 µg/g, injected intracerebrally, the peptides produced depression; at ∼ 1 µg/g, injected intracerebrally, the peptides caused effects similar to those of cerebral stroke (paralysis, severe depression). These effects were dependent on the peptide concentration used for injection: they were more severe when smaller volumes with a higher peptide concentration were used, although the doses were equal. At doses of ∼ 2 µg/g, injected intraperitoneally, Ltc 2a showed effects that are usual for cytolytic compounds (seizures, urination, defecation), whereas CIT 1a was less active and produced only mild depression at 5 µg/g.
Artificial membrane and vesicle studies
Synthetic CIT 1a was studied for lytic effects on artificial bilayers formed from DPhPC and DOPE/DOPG (7:3, w/w) that mimicked eukaryotic and prokaryotic plasma membranes respectively. The peptide caused fast (< 30 s) membrane rupture at submicromolar concentrations. All effects were concentrationand voltage-dependent; lesser peptide concentrations were able to produce lytic effects at higher negative membrane potentials (0.1 and 0.15 µM for anionic DOPE/DOPG membranes at −100 and −70 mV holding membrane potential respectively; 0.4 and 0.5 µM for zwitterionic DPhPC at the same membrane potentials). At lower concentrations, a slow rise in membrane permeability was observed without membrane breakdown. We note similar activity with lactarins, which are short cytolytic peptides [2] .
CIT 1a was compared with Ltc 2a for the ability to release ANTS/DPX fluorescent dye/quencher from LUVs with different lipid compositions (Figure 6 ). Both peptides were much more effective on LUVs prepared from anionic lipids (DOPE/DOPG; 7:3, w/w) than from zwitterionic DPhPC. Different results were obtained on total lipid extracted from flesh fly larvae. CIT 1a was relevantly more effective on vesicles consisting of total larvae lipid than DPhPC, whereas Ltc 2a, a reference cytolytic peptide, was non-selective.
DISCUSSION
Novel class of spider venom components
CITs represent a novel class of spider venom constituents. The absence of cysteine residues differentiates this class from spider venom neurotoxins most usually belonging to the ICK type, whereas the polypeptide chain length differentiates them from conventional venom cytolytic peptides that usually consist of ∼ 20-30 amino acid residues [1, 3] . Before the present work, the longest linear peptide from spider venom was oxyopinin 1, a cytolytic AMP from Oxyopes kitabensis with 48 residues [4] . The longest linear cytolytic peptide from the phylum Arthropoda was pilosulin 1 from the jumper ant Myrmecia pilosula with 55 residues [14] .
Except for the unprecedented length, however, other structural features observed in CITs are usual for a class of molecules known as linear α-helical AMPs. Indeed, we have shown that CITs are: (i) linear; (ii) cationic; (iii) amphiphilic, as seen from their primary and secondary structures; (iv) have a high α-helical propensity, as is evident from CD measurements under different conditions; (v) interact with membranes, as suggested by CD, planar bilayer and LUV lysis studies; (vi) produce lytic effects on different types of cells, including micro-organisms, as shown directly in biological testing.
However, a major difference was observed in the biological activities of the two classes of molecules, i.e. CITs and short α-helical AMPs. CITs were found to be insecticidal, whereas short AMPs were moderately toxic. Indeed, the LD 50 value (20 µg/g for Sarcophaga carnaria flesh fly larvae) found for CIT is low compared with that of spider venom AMPs latarcins (> 100 µg/g for flesh fly larvae) and oxyopinins (> 800 µg/g for Spodoptera litura larvae, the tobacco cutworm) [4] . A similar toxicity was shown for cupiennins (∼ 20 µg/g for Drosophila melanogaster adult fruit flies) [7] , but CITs were more active on adult flesh flies (LD 50 of ∼ 5 µg/g). However, standardization is clearly needed to estimate relative insecticidal activities of the toxins, since different insects are used for experiments in different laboratories.
Whereas the exact role of AMPs in spider venom is under question [1] , we suggest that CIT function is obviously insecticidal. Moreover, compared with short cytolytic peptides latarcins from the same spider venom [2] , CITs show a high degree of specificity towards insects and insect cells as clearly demonstrated in the toxicity experiments. Although CIT 1a was much more active on insects than Ltc 2a, the most potent latarcin, it was found to be equally or less active on mice. CIT 1a was 20-fold more active on insect Sf9 cells than Ltc 2a, but was almost as active as Ltc 2a against cells of different origins, including bacteria and erythrocytes [2] .
Experiments with model membranes and LUVs show that the mode of CIT action is most probably membrane-disruptive. The mechanism of CIT action is suggested to be similar to that of many other AMPs consistent with the so-called 'carpet' model [15] . However, the specificity of action, membrane selectivity depending on the lipid content and/or membrane potential is obvious. CIT 1a, as with latarcins, was more active on anionic membranes in both planar lipid bilayer and artificial vesicle assays. To test the possibility of specificity towards insect lipids, we prepared LUVs from the total lipid extracted from fly larvae. CIT 1a was less active on LUVs from zwitterionic DPhPC lipids only, whereas Ltc 2a was non-selective. The differences were rather small, therefore CIT specificity is most probably not provided by the total lipid composition. The more subtle peculiarities of insect cell membranes could be lost during lipid extraction. Because the primary effect of CITs on insects is paralytic, membranes of neurons and/or muscle cells seem to be the main target. We suggest that a combination of a specific lipid content and membrane potential in insect electro-excitable cells could be the reason underlying CIT specificity.
Evolution towards modular toxins
The spider L. tarabaevi has evolved to produce CITs, the elaborate cytolytic molecules that show specificity towards insects. In this respect, the sequence organization of CIT provides an interesting clue.
The structure of CIT could be presented as a doubled AMP, a modular structure where two short linear AMPs are combined to form a longer polypeptide chain in a 'head-totail' orientation (AMP-AMP). CIT fragments 1-34 and 39-69 represent sequences that show characteristics very common to short α-helical AMPs. They have a large positive net charge at pH 7.0 (+ 9 and + 7 respectively), and a large propensity to form α-helices (as suggested by several prediction methods [16, 17] ) with clusters of hydrophobicity and positive charge on the opposite facets. Such amphiphilic structures are known to effectively interact with membranes, and are the hallmark of α-helical AMPs [18] .
The two fragments are separated with a short linker sequence EEAQ (Glu-Glu-Ala-Gln) or EEAE (Glu-Glu-Ala-Glu) (residues 35-38). This sequence is reminiscent of the PQM known to specify the propeptide cleavage point in the precursors of peptides secreted by the venom glands of spiders, both neurotoxins and AMPs [2, 13] . In L. tarabaevi, the most common PQM sequence appears to be EEAR (Glu-Glu-Ala-Arg), common to latarcin and CIT precursors ( Figure 4 ) [2] . We therefore suggest that the linker sequence in mature CIT is a mutated or cryptic PQM from which an arginine residue is missing. For this reason, the two short AMPs (fragments 1-34 and 39-69) are no longer separated during the propeptide processing and are held together in one chain. We suppose that CIT propeptides were once serving precursors to two different mature peptides just like latarcin binary precursors [2] , but were later transformed into simple precursors because of a mutation in the PQM. This mutation was kept during L. tarabaevi evolution, possibly because it brought about some positive effect. Indeed, the CITs, the novel type of modular molecules that were produced, had insect-specific toxicity obviously most useful for the spider biology. Although the presented evolutionary sequence (binary precursor to simple precursor via PQM mutation) is a speculation and should be treated as such, it provides an interesting insight into spider toxin structure evolution towards complex molecules with newly tuned functions.
The proposed modular organization of CIT is in line with the recently discovered scorpine family of AMPs, modular peptides from the venom of scorpions Pandinus imperator and Opistophthalmus carinatus belonging to the family Scorpionidae [19, 20] . Molecules of scorpines comprise two different domains: N-terminal linear α-helical domain, showing similarities to many AMPs including the classical cecropins, and a C-terminal CSαβ (cysteine-stabilized α-helix/β-sheet) domain, common to a wealth of peptides, including scorpion neurotoxins and plant defensins. We believe that elaborate modular toxin design is a common feature of different venomous creatures and that interesting discoveries are still ahead. Together with the present study, two types of modular toxins are known: AMP-AMP (CITs) and AMP-CSαβ (scorpines).
Unique venom composition profile
Although spider venoms represent complex mixtures of chemically diverse compounds (ions, biogenic amines, polyamines, polypeptide neurotoxins, cytolytic peptides, enzymes, etc.), preference is usually given to one class of molecules that constitutes a major part of the crude venom. Among the spiders investigated, L. tarabaevi is found to be unique in terms of its venom composition, or the toxin repertoire.
Most of the spiders studied to date demonstrate venom composition that is more or less based on the ICK type of molecules [3, 5, 21] . Up to several hundred structurally related molecules sharing the same fold stabilized by conserved cysteine residues are simultaneously present in the same venom [22] . The specificity of action of each molecule, on the other hand, is determined by the unique residues located in loops between the disulfide bridges. This assembly of venom peptides is often referred to as naturally edited combinatorial libraries and is very common to different spiders [5, 23, 24] .
At least two vivid exceptions to this trend are known to date: (i) the widow spiders from the genus Latrodectus produce highly structurally and functionally specific large protein neurotoxins, the latrotoxins [25] ; and (ii) the orb weavers from the family Araneidae produce a large selection of acylpolyamine toxins that are moderately specific [26] . All of the described types of venom composition ('ICK-based', 'large-protein-based', and 'acylpolyamine-based') are nevertheless common, i.e. they are all 'neurotoxic-based'.
In contrast, L. tarabaevi venom composition was found to be 'cytolytic-based'. The cytolytic peptides latarcins, CITs and others (yet to be reported) together constitute no less than 40 % of the total venom (preliminary estimate). At some point during L. tarabaevi evolution, the cytolytic peptides were probably found to be safe to rely upon, and finally occupied a larger part of the crude venom. Other spiders also produce venoms which are relatively abundant in cytolytic components; these are from the superfamily Lycosoidea, containing the wolf spiders Lycosa carolinensis and Lycosa singoriensis from the family Lycosidae [6, 27] , the lynx spiders Oxyopes kitabensis from the family Oxyopidae [4] , and the wandering spiders Cupiennius salei from the family Ctenidae [7] . However, in each case, a larger and/or more functionally important part of the venom is represented by cysteine-containing neurotoxins of the ICK-type. Therefore we consider the venom composition of these spiders to be 'intermediate neurotoxiccytolytic', whereas L. tarabaevi appears to be an 'expert' in cytolytics. This brings L. tarabaevi together with bees, bumblebees, wasps and ants, all of which have cytolytic peptides as major compounds in their venom [1, 8, 9, 28, 29] .
At least two strategies of tuning a cytolytic-based venom composition can be inferred at this point. One is exemplified by the honey bee, which almost fully relies on just a few venom components. The major components are the peptide melittin and the enzyme phospholipase A 2 , both of which show broad cytolytic activity [8, 30] . The other strategy implies a wide biomolecular diversity of venom constituents that is common to a vast number of venomous animals [3, 21, 31] . In the case of cytolytic-based venoms, a large number of homologous and non-homologous molecules aimed to exert lytic action are produced simultaneously. This trend is followed by the ant Pachycondyla goeldii that produces 15 short linear cationic peptides (ponericins) classified into three unrelated structural groups [9] . The spider L. tarabaevi clearly serves as a perfect example of the second strategy.
The mechanisms that form the observed biomolecular diversity of components are similar in neurotoxic-based and cytolyticbased venoms. Indeed, the biosynthetic pathway is universal for venom neurotoxins and AMPs; accordingly, the precursor structures are organized similarly. Most AMPs from L. tarabaevi venom (latarcins and CITs) have a simple type of precursor structure that is also typical for spider neurotoxins: prepropeptide with an acidic N-terminal prosequence separated from the mature chain with a PQM. The prepro-regions of the precursors are conserved, whereas the mature chains show a high level of variability (Figure 4 ). This feature of concentrating mutations to the regions coding for the mature chains is referred to as accelerated evolution and is found in toxin genes of venomous animals that show biomolecular diversity of venom polypeptide components [32] [33] [34] .
In conclusion, we note that the new class of molecules described in the present paper (long linear peptides with modular organization) adds to the unique versatility of spider polypeptide toxins ranging from simple short linear peptides, small disulfiderich molecules to more elaborate modular structures and large proteins.
